Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.

  • Björn Sjöstrand Björn Sjöstrand
  • Björn Gustavsson Björn Gustafsson
  • Peter Liss sv Peter Liss
  • helena_päärni Helena Päärni
  • mikael_vikström Mikael Vikström
  • Tobias skarin Tobias Skarin

Charlotte Flodin joins Scandinavian Biopharma as VP Quality Assurance

2017-11-06

Scandinavian Biopharma continues to expand and strengthen its organization. In August Charlotte Flodin started as VP Quality Assurance. – I am very excited to take part in the journey to develop a new vaccine – ETVAX®,” says Charlotte Flodin, who will be responsible for Quality Assurance. With my previous experience of drug development and manufacturing […]

Jonas Bengtsson joins Scandinavian Biopharma as VP Business Development and International Sales

2017-10-05

Jonas Bengtsson joins Scandinavian Biopharma with more than 20 years of experience from the vaccine-, pharmaceutical- and medtech-industry including, Sales, Marketing, Business Development and Licensing.  His strategic business thinking, his track record of delivering results and his experience around the world are key to accompany Scandinavian Biopharma on its growth path. Jonas started to work […]

New ETVAX® data will be presented during Vaccines for Enteric Diseases (VED) conference

2017-10-04

The 9-11 October “Vaccines for Enteric Diseases” (VED2017) will be organized in Albufeira, Portugal. This meeting gathers experts on vaccines and enteric infections and advocates for global health improvement to address and discuss the diverse aspects of vaccines to human enteric diseases. Our ETEC-vaccine, ETVAX®, is of course on the agenda when the global development of […]